Skip to content

Moderna Inc Sustainability Reports

Moderna, Inc. is a pharmaceutical and biotechnology company focused on inventing and developing transformative medicines using messenger RNA (mRNA) technology. The company develops and manufactures vaccines and therapeutics for infectious diseases, immuno-oncology, rare genetic illnesses, and cardiovascular disorders.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 549300EI6OKH5K5Q2G38

FIGI: BBG003PHHZV8

15 reports from 2018 to 2025